By
AmyT on
November 13, 2009
Today, just a sampling of some of the interesting stuff presented at last week’s Diabetes Technology Society meeting, that will be out on the market in … um… some years from now (?):
IN-105 Oral Insulin for Type 2 diabetes – Biocon Limited, apparently India’s premier biotechnology company, has been developing oral insulin tablets for some years now. Positive research results were announced last year. And they’re not just for basal use, either. Studies confirmed…
Read more »
By
AmyT on
November 1, 2009
Hope you all had a fun Halloween weekend. Somehow the conclusion of that sugar-fest seems a great segue into National Diabetes Awareness Month, no? And the countdown begins to World Diabetes Day on Nov. 14, 2009.
Where to begin describing all the activities planned around the web and around the world to “bring diabetes to light” this month…?
Let’s start with the most fun campaign, the brainchild of Manny Hernandez of TuDiabetes, called the THE…
Read more »
By
AmyT on
October 19, 2009
Some people were surprised recently to hear me say that tools for logging glucose are “not the Holy Grail of online diabetes tools.” I stand by that assertion, and I’m going to tell you why.
There are an ever-increasing number of PC and phone-based programs that allow diabetics to log and share their BG data. While this can be useful for some, there are several shortcomings for the general PWD population, the way I see…
Read more »
By
AmyT on
September 11, 2009
Browsing through the latest issue of Wired magazine (my favorite print pub!), I stumbled upon a “reader rant” that stopped me in my tracks. A guy named Edward Aboufadel from Ada, Michigan, was responding to a recent article titled Living by Numbers, about our new data-driven lifestyles. He writes:
People who are really ‘living by numbers’ are type 1 diabetics, who struggle every day to keep their blood glucose in range with carbohydrate counts, insulin…
Read more »
By
AmyT on
August 24, 2009
Did any of you catch this excellent article in the New York Times last week: Diabetes Case Shows Pitfalls of Treatment Guidelines? I was surprised to see very little blog chatter on it. It’s a fascinating summary of the recent controversy over national blood sugar guidelines, sparked primarily by the ACCORD study that scared everybody off tight glucose control last summer.
The article explains how the benchmark for aggressive control of blood sugar was abruptly…
Read more »
